Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00528021 · ClinicalTrials.gov registry record · Phase 2
A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation
A Phase 2 study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 230
- Enrollment target
NCT00528021 is a Phase 2 study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 230 participants.
The verdict
NCT00528021, a Phase 2 study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 230 participants
- Enrollment target
Study Summary
The main purpose of this study is to investigate the safety and efficacy of an investigational treatment for head lice infestation against a placebo.
Interventions
- DRUG Placebo
- DRUG BGC20-0582
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2007-08 |
| Est. Completion | 2008-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00528021
The ClinicalTrials.gov registry entry for NCT00528021 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00528021 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00528021 about?
NCT00528021 is a clinical study titled "A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation". The main purpose of this study is to investigate the safety and efficacy of an investigational treatment for head lice infestation against a placebo.
What is the current status of trial NCT00528021?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 230 participants. The study started on 2007-08. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00528021?
The interventions under investigation include: Placebo (DRUG), BGC20-0582 (DRUG).
Who is sponsoring clinical trial NCT00528021?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.